Index S&P 500
P/E -
EPS (ttm) -0.74
Insider Own 2.44%
Shs Outstand 1.19B
Perf Week -0.71%
Market Cap 15.08B
Forward P/E 4.74
EPS next Y 2.66
Insider Trans -3.23%
Shs Float 1.16B
Perf Month -2.85%
Income -883.30M
PEG -
EPS next Q 0.58
Inst Own 79.61%
Short Float 1.77%
Perf Quarter 6.94%
Sales 15.03B
P/S 1.00
EPS this Y -8.42%
Inst Trans -2.17%
Short Ratio 2.68
Perf Half Y 24.19%
Book/sh 16.58
P/B 0.76
EPS next Y -0.93%
ROA -1.89%
Short Interest 20.60M
Perf Year 24.68%
Cash/sh 1.66
P/C 7.63
EPS next 5Y -3.41%
ROE -4.35%
52W Range 9.82 - 13.62
Perf YTD 16.62%
Dividend Est. -
P/FCF 7.74
EPS past 5Y -41.87%
ROI -2.58%
52W High -7.25%
Beta 0.95
Dividend TTM 0.48 (3.80%)
Quick Ratio 0.88
Sales past 5Y 7.93%
Gross Margin 40.92%
52W Low 28.63%
ATR (14) 0.32
Dividend Ex-Date Nov 22, 2024
Current Ratio 1.43
EPS Y/Y TTM -148.59%
Oper. Margin 9.48%
RSI (14) 47.73
Volatility 2.88% 2.37%
Employees 38000
Debt/Eq 0.81
Sales Y/Y TTM -2.55%
Profit Margin -5.88%
Recom 3.09
Target Price 13.17
Option/Short Yes / Yes
LT Debt/Eq 0.73
EPS Q/Q -71.23%
Payout 1059.60%
Rel Volume 0.89
Prev Close 12.82
Sales Surprise 0.96%
EPS Surprise 10.82%
Sales Q/Q -4.30%
Earnings Nov 07 BMO
Avg Volume 7.69M
Price 12.63
SMA20 -2.75%
SMA50 2.62%
SMA200 8.66%
Trades
Volume 6,871,793
Change -1.48%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-19-24 Resumed
Jefferies
Buy
$15
Oct-23-23 Downgrade
BofA Securities
Neutral → Underperform
$13 → $9
Jun-23-23 Downgrade
Barclays
Equal Weight → Underweight
$11
Apr-24-23 Downgrade
Barclays
Overweight → Equal Weight
$11
Feb-17-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$16 → $14
Jan-27-23 Upgrade
Jefferies
Hold → Buy
$13 → $15
Nov-10-22 Upgrade
UBS
Sell → Neutral
$9 → $12
Nov-08-22 Upgrade
Piper Sandler
Underweight → Neutral
$10
Oct-21-22 Resumed
Jefferies
Hold
$11
Jun-14-22 Initiated
UBS
Sell
$9
May-10-22 Downgrade
Piper Sandler
Neutral → Underweight
$10
Mar-01-22 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-01-22 Downgrade
BofA Securities
Buy → Neutral
$21 → $13
Jun-15-21 Initiated
Citigroup
Neutral
$16
Apr-07-21 Resumed
RBC Capital Mkts
Outperform
$24
Mar-08-21 Downgrade
Goldman
Buy → Neutral
$20 → $15
Mar-02-21 Downgrade
JP Morgan
Overweight → Neutral
$21 → $18
Feb-26-21 Downgrade
Wolfe Research
Outperform → Peer Perform
$17
Jan-05-21 Initiated
Argus
Hold
Dec-14-20 Initiated
Bernstein
Mkt Perform
$21
Show Previous Ratings
Dec-02-24 08:30AM
Nov-21-24 08:51AM
Nov-11-24 11:01AM
(Pharmaceutical Technology)
Nov-08-24 02:14AM
Nov-07-24 05:02PM
04:46PM
Loading…
04:46PM
09:30AM
08:25AM
07:27AM
(Associated Press Finance)
06:59AM
Nov-05-24 06:59AM
Nov-04-24 09:16AM
Oct-29-24 12:00PM
09:00AM
02:00AM
07:15AM
Loading…
Oct-17-24 07:15AM
05:55AM
(Pharmaceutical Technology)
Oct-16-24 04:35PM
04:34PM
Oct-15-24 06:27PM
Oct-14-24 01:40PM
Oct-12-24 11:16AM
Oct-10-24 10:15AM
Oct-09-24 05:38PM
06:59AM
Oct-08-24 03:40PM
11:23AM
Oct-07-24 04:15PM
Oct-01-24 10:50AM
Sep-30-24 06:59AM
01:25PM
Loading…
Sep-19-24 01:25PM
11:05AM
Sep-18-24 11:30AM
Sep-17-24 08:45PM
Sep-16-24 04:30PM
10:45AM
09:04AM
Sep-12-24 10:15AM
Sep-10-24 07:00PM
11:40AM
Sep-09-24 10:15AM
Sep-04-24 11:55AM
03:30AM
Sep-02-24 06:33AM
(Pharmaceutical Technology)
Aug-23-24 06:59AM
Aug-20-24 05:30AM
Aug-09-24 09:30AM
01:05AM
Aug-08-24 04:02PM
(Morningstar Research) +6.51%
01:19PM
11:52AM
09:53AM
08:10AM
07:08AM
(Associated Press Finance)
06:59AM
Aug-07-24 09:02AM
Aug-06-24 06:04PM
06:59AM
Aug-05-24 04:42PM
09:16AM
Aug-01-24 10:01AM
Jul-31-24 10:09AM
Jul-30-24 09:00AM
Jul-29-24 10:30AM
Jul-26-24 12:25PM
Jul-25-24 01:00AM
Jul-23-24 10:30AM
Jul-18-24 02:45PM
Jul-04-24 11:33AM
(Pharmaceutical Technology)
Jul-03-24 08:30AM
Jul-02-24 07:30AM
Jun-25-24 05:25PM
Jun-07-24 06:59AM
Jun-04-24 06:59AM
Jun-03-24 06:59AM
May-31-24 06:59AM
May-29-24 02:39AM
May-22-24 11:13AM
May-21-24 06:30PM
12:50AM
May-10-24 02:32PM
12:23PM
11:12AM
08:00AM
May-09-24 10:10PM
(Thomson Reuters StreetEvents)
04:23PM
12:48PM
11:56AM
11:06AM
10:30AM
08:24AM
08:10AM
07:30AM
07:06AM
(Associated Press Finance)
06:59AM
May-08-24 11:19AM
May-06-24 09:50AM
09:16AM
May-02-24 05:00PM
10:01AM
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Campbell Paul See Remarks Nov 11 '24 Sale 12.88 26,925 346,686 126,901 Nov 12 07:00 PM Campbell Paul Officer Nov 11 '24 Proposed Sale 12.88 26,925 346,686 Nov 12 04:30 PM Malik Rajiv Director Sep 12 '24 Sale 11.66 139,681 1,628,164 505,838 Sep 13 06:00 PM Malik Rajiv Director Sep 12 '24 Sale 11.71 60,319 706,553 0 Sep 13 06:00 PM Malik Rajiv Director Aug 30 '24 Sale 12.00 50,000 600,000 60,319 Aug 30 06:16 PM Malik Rajiv Director Aug 28 '24 Sale 11.90 50,000 595,075 110,319 Aug 30 06:16 PM Malik Rajiv Director Aug 21 '24 Sale 11.75 100,000 1,175,260 360,319 Aug 23 06:05 PM Malik Rajiv Director Aug 23 '24 Sale 11.75 100,000 1,175,100 160,319 Aug 23 06:05 PM Malik Rajiv Director Aug 22 '24 Sale 11.73 100,000 1,172,630 260,319 Aug 23 06:05 PM Malik Rajiv Director Aug 20 '24 Proposed Sale 11.80 600,000 7,080,000 Aug 20 12:07 PM Malik Rajiv Director Jun 14 '24 Sale 10.18 264,300 2,690,283 645,519 Jun 17 06:00 PM Malik Rajiv Director Jun 13 '24 Sale 10.52 85,660 900,741 909,819 Jun 17 06:00 PM Roman Brian Chief Legal Officer May 28 '24 Sale 10.38 89,419 928,429 67,723 May 28 06:00 PM Mauro Anthony See Remarks Mar 13 '24 Sale 12.09 250,000 3,023,700 243,044 Mar 15 06:00 PM Campbell Paul See Remarks Mar 04 '24 Option Exercise 0.00 19,427 0 185,132 Mar 05 08:36 PM Campbell Paul See Remarks Mar 03 '24 Option Exercise 0.00 18,560 0 174,518 Mar 05 08:36 PM Campbell Paul See Remarks Mar 02 '24 Option Exercise 0.00 90,297 0 180,524 Mar 05 08:36 PM Campbell Paul See Remarks Mar 05 '24 Sale 12.33 24,353 300,272 153,826 Mar 05 08:36 PM Mauro Anthony See Remarks Mar 04 '24 Option Exercise 0.00 39,784 0 507,164 Mar 05 08:35 PM Mauro Anthony See Remarks Mar 03 '24 Option Exercise 0.00 37,835 0 485,243 Mar 05 08:35 PM Mauro Anthony See Remarks Mar 02 '24 Option Exercise 0.00 192,630 0 499,154 Mar 05 08:35 PM Roman Brian Global General Counsel Mar 04 '24 Option Exercise 0.00 18,650 0 163,817 Mar 05 08:29 PM Roman Brian Global General Counsel Mar 03 '24 Option Exercise 0.00 17,598 0 153,541 Mar 05 08:29 PM Roman Brian Global General Counsel Mar 02 '24 Option Exercise 0.00 84,277 0 158,905 Mar 05 08:29 PM CORNWELL W DON Director Mar 03 '24 Option Exercise 0.00 18,855 0 61,365 Mar 05 08:29 PM FINNEY ELISHA W Director Mar 03 '24 Option Exercise 0.00 18,855 0 18,855 Mar 05 08:25 PM Groothuis Leo Frans Director Mar 03 '24 Option Exercise 0.00 22,484 0 22,154 Mar 05 08:24 PM KORMAN HARRY Director Mar 03 '24 Option Exercise 0.00 18,855 0 89,806 Mar 05 08:23 PM KILTS JAMES M Director Mar 03 '24 Option Exercise 0.00 18,855 0 117,445 Mar 05 08:22 PM Lyons Dillon JoEllen Director Mar 03 '24 Option Exercise 0.00 18,855 0 78,714 Mar 05 08:19 PM Lyons Dillon JoEllen Director Mar 05 '24 Sale 12.36 20,000 247,200 58,714 Mar 05 08:19 PM PARRISH MARK W Director Mar 03 '24 Option Exercise 0.00 18,855 0 121,418 Mar 05 08:17 PM MARK RICHARD A Director Mar 03 '24 Option Exercise 0.00 18,855 0 72,333 Mar 05 08:14 PM HIGGINS MELINA E Director Mar 03 '24 Option Exercise 0.00 18,855 0 102,236 Mar 05 08:13 PM Ni Xiangyang (Sean) President, Greater China Mar 04 '24 Option Exercise 0.00 8,222 0 112,336 Mar 05 08:09 PM Ni Xiangyang (Sean) President, Greater China Mar 03 '24 Option Exercise 0.00 14,298 0 104,114 Mar 05 08:09 PM Ni Xiangyang (Sean) President, Greater China Mar 02 '24 Option Exercise 0.00 25,158 0 89,816 Mar 05 08:09 PM Ni Xiangyang (Sean) President, Greater China Mar 04 '24 Sale 12.51 21,532 269,314 90,804 Mar 05 08:09 PM Malik Rajiv President Mar 04 '24 Option Exercise 0.00 89,514 0 1,027,249 Mar 05 08:09 PM Malik Rajiv President Mar 03 '24 Option Exercise 0.00 85,788 0 978,180 Mar 05 08:09 PM Malik Rajiv President Mar 02 '24 Option Exercise 0.00 433,416 0 1,008,849 Mar 05 08:09 PM Smith Scott Andrew Chief Executive Officer Mar 03 '24 Option Exercise 0.00 140,727 0 135,829 Mar 05 08:01 PM Cuneo Andrew See Remarks Mar 04 '24 Option Exercise 0.00 6,838 0 62,542 Mar 05 07:47 PM Cuneo Andrew See Remarks Mar 03 '24 Option Exercise 0.00 13,199 0 61,485 Mar 05 07:47 PM Cuneo Andrew See Remarks Mar 02 '24 Option Exercise 0.00 25,692 0 52,167 Mar 05 07:47 PM Cuneo Andrew See Remarks Feb 23 '24 Sale 13.50 4,000 54,000 34,795 Feb 23 06:00 PM Cuneo Andrew See Remarks Feb 15 '24 Sale 12.50 4,000 50,000 38,795 Feb 16 06:00 PM Cuneo Andrew See Remarks Jan 04 '24 Sale 11.50 4,000 46,000 42,795 Jan 05 06:00 PM Cuneo Andrew See Remarks Dec 14 '23 Sale 10.50 4,000 42,000 46,795 Dec 15 06:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite